Cargando…
Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures
It is currently estimated that about 20%–30% of adults and 10%–40% of children diagnosed with epilepsy suffer from uncontrolled or poorly controlled seizures, despite optimal medical management. In addition to its huge economic costs, treatment-refractory epilepsy has a widespread impact on patients...
Autores principales: | Mitchell, James W., Seri, Stefano, Cavanna, Andrea E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619658/ https://www.ncbi.nlm.nih.gov/pubmed/23650471 http://dx.doi.org/10.4137/JCNSD.S8315 |
Ejemplares similares
-
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
por: Tolman, Justin A, et al.
Publicado: (2011) -
Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009) -
Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
por: Carson, Kristin V., et al.
Publicado: (2013) -
Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
por: Di Stefano, Giulia, et al.
Publicado: (2021) -
Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures
por: Puskarjov, Martin, et al.
Publicado: (2014)